Stock-Based Compensation Plans (Tables)

3 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock compensation expense

The Company recorded the following Stock compensation expense in its consolidated statements of income (in thousands):

	Three Months ended				Nine months ended
	September 30,				September 30,
	2023		2022		2023		2022
Stock option grants	$	16		18		49		52
Restricted stock awards		255		258		773		550
Employee stock grant		—		—		50		50
Annual director stock award		—		—		600		650
	$	271		276		1,472		1,302

Summary of changes in outstanding options

A Summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

				Weighted		Weighted	Weighted
	Number			Average		Average	Average
	Of			Exercise		Remaining	Grant Date
Options	Shares			Price		Term (yrs)	Fair Value(000's)
Outstanding at January 1, 2023		88,295		$	40.33	4.4	$	1,271
Exercised		(17,735	)	$	45.27		$	(190	)
Outstanding at September 30, 2023		70,560		$	39.09	3.3	$	1,081
Exercisable at September 30, 2023		66,570		$	38.68	3.2	$	1,015
Vested during nine months ended September 30, 2023		—					$	—

Summary of changes in restricted stock awards

A Summary of changes in restricted stock awards is presented below (in thousands, except share and per share amounts):

				Weighted		Weighted	Weighted
	Number			Average		Average	Average
	Of			Grant Date		Remaining	Grant Date
Restricted stock	Shares			Fair Value		Term (yrs)	Fair Value(000's)
Non-vested at January 1, 2023		50,496		$	50.42	3.0	$	2,546
Time-based awards granted		7,980			53.86			430
Performance-based awards granted		17,304			53.92			933
Vested		(6,211	)		46.49			(289	)
Non-vested at September 30, 2023		69,569		$	52.03	2.8	$	3,620